Clinical development of oxamniquine in Egypt.
D000293:Adolescent; D000328:Adult; D000818:Animals; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D004534:Egypt; D005260:Female; D006801:Humans; D008297:Male; D009600:Nitroquinolines / Q000627:therapeutic use*; D010073:Oxamniquine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010270:Parasite Egg Count; D010865:Pilot Projects; D012548:Schistosoma haematobium; D012550:Schistosoma mansoni; D012552:Schistosomiasis / Q000188:drug therapy*; D014236:Trichlorfon / Q000008:administration & dosage
D009600:Nitroquinolines; D010073:Oxamniquine; D014236:Trichlorfon